The Biotech Revolution in Big Pharma Organisation

IEEE International Engineering Management Conference

Volumn , Issue , 2003, Pages 514-518

  Chiaroni, Davide ^a   Chiesa, Vittorio ^a   Toletti, Giovanni ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b POLITECNICO DI MILANO   (Italy)

Author keywords

Big Pharma; Biotechnology; Organisation

Indexed keywords

CUSTOMER SATISFACTION; DRUG PRODUCTS; INDUSTRIAL RELATIONS; MARKETING; RESEARCH AND DEVELOPMENT MANAGEMENT; SALES; SOCIETIES AND INSTITUTIONS;

BIG PHARMAS; THERAPEUTICS;

BIOTECHNOLOGY;

EID: 1142263386     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (7)

1. AA.VV., "Pharmaceutical industry profile 2002", PhRMA (2002).
2. Altshuler, J., Flanagan, A, et al., "A revolution in R&D - How genomics and genetics are transforming the biopharmaceutical industry", The Boston Consulting Group (2002).
3. Burrill&Company, "Biotech 2003. Life sciences: Revaulation and Restructuring..." (2003).
4. rd edition, (2001).
5. Chiesa, V., R&D Strategy and organisation, managing technical change in dynamic contexts, Imperial College Press (2001).
6. Ernst&Young, "Endurance. The biotechnology industry report" (2003).
7. IBM Business Consulting Services, "Pharma 2010: The Threshold of Innovation" (2003).